Intel's 300%+ rally may be overvalued at 73x earnings; Broadcom's 29% revenue growth justifies its valuation.
IMAX jumps 2.8% on record biopic debut! Revenue up 16.47%, EPS 51.58%. Still 12.5% below 52-week high.
SpaceX IPO eyes $2T valuation, P/S > 100. AMZN offers better value at P/E 36.
WBTN jumps 6% on AI avatar deal, but remains volatile & down 10.8% YTD.
AESI jumps 2.9% on oil spike; GPRE up 2.6%. AESI's 74% YTD gain hits new highs.
VZ beats EPS estimates, boosting shares 3%. Mixed revenue, but strong cash flow outlook signals value.
Teva's pivot shows growth in key drugs like Austedo (34% sales jump). Q1 earnings may dip, but 2027 EPS targets rise 17%.
Sponsored
Must Read